Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 30, 2025
Isolated adrenocorticotropic hormone deficiency manifested after COVID-19Ryo Shimba, Shunichiro Hanai, Ryosuke Ito, et al.
International Archives of Allergy and Immunology|June 8, 2011
STAT4 is required for IFN-β-induced MCP-1 mRNA expression in murine mast cellsKazuma Iida, Kotaro Suzuki, Masaya Yokota, et al.
The Journal of Allergy and Clinical Immunology. Global|May 29, 2026
Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomesYoshiaki Kobayashi, Daiki Nakagomi, Shunichiro Hanai, et al.
The Journal of Rheumatology|May 15, 2025
Efficacy of Tumor Necrosis Factor Inhibitors for Refractory Leg Ulcers in Cutaneous Polyarteritis Nodosa: A Case SeriesKimie Harama, Takao Sugiyama, Chisaki Ito, et al.
The Journal of Investigative Dermatology|March 26, 2016
SOCS3 Expressed in M2 Macrophages Attenuates Contact Hypersensitivity by Suppressing MMP-12 ProductionKazuyuki Meguro, Daiki Nakagomi, Kotaro Suzuki, et al.
The Journal of Rheumatology|November 5, 2013
Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agentsKei Ikeda, Daiki Nakagomi, Yoshie Sanayama, et al.
Plos One|October 4, 2011
Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activationKotaro Suzuki, Samantha H Murphy, Yifeng Xia, et al.
Immunological Medicine|February 5, 2026
Clinical relevance of serum lysozyme in sarcoidosis with kidney impairmentShunichiro Hanai, Yoshiaki Kobayashi, Kojiro Ikeda, et al.
RMD Open|February 9, 2023
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort studyKazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, et al.
Internal Medicine (Tokyo, Japan)|September 3, 2025
Risk of Kidney Impairment during Iguratimod Therapy for Rheumatoid Arthritis Patients: The Role of Concomitant SalazosulfapyridineShunichiro Hanai, Yoshiaki Kobayashi, Moe Watanabe, et al.
Pageof 8